PHARMINOX LTD has a total of 32 patent applications. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization), United Kingdom and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are KIREMIRE ENOS, GEANGE LTD and ASTA WERKE AG CHEM FAB.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | United Kingdom | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Australia | 2 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | Israel | 2 | |
#8 | United States | 2 | |
#9 | Argentina | 1 | |
#10 | Brazil | 1 | |
#11 | Hong Kong | 1 | |
#12 | Peru | 1 | |
#13 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Name | Total Patents |
---|---|---|
#1 | Cousin David | 18 |
#2 | Hummersone Marc Geoffery | 17 |
#3 | Stevens Malcolm Francis Graham | 11 |
#4 | Mccarroll Andrew James | 8 |
#5 | Zhang Jihong | 7 |
#6 | Williams John Gareth | 7 |
#7 | Jennings Sharon | 7 |
#8 | David Cousin | 4 |
#9 | Geoffery Hummersone Marc | 3 |
#10 | Graham Stevens Malcolm Francis | 3 |
Publication | Filing date | Title |
---|---|---|
WO2012175991A1 | Fused pentacyclic anti - proliferative compounds | |
GB201205504D0 | Novel anti-proliferative compounds | |
WO2012085501A1 | 8 - sulfo - imidazotetrazin- 4 - one compounds and their use as anticancer drug | |
GB201110727D0 | Novel anti-proliferative compounds | |
US2013012706A1 | Methods and Intermediates for the Synthesis of 4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazines | |
GB201016442D0 | Novel acridine derivatives | |
WO2010149968A1 | 3-substituted-8-substituted-3h imidazo[5,1-d][1,2,3,5-tetrazin-4-one compounds and their use | |
GB0905127D0 | Novel prodrugs | |
CN101945874A | 3-substituted-4-0x0-3, 4-dihydro-imidazo- [5, 1-d] [1,2,3,5] -tetrazine-8-carboxylic acid amides as anticancer agents | |
GB0407351D0 | Pharmaceutical compositions |